The goals of this research are to delineate the cis-acting signals, identify the trans-acting factors and elucidate the mechanisms that regulate human cytomegalovirus (CMV) gene expression at the translational level. Investigations of the molecular basis of CMV translational control will reveal both viral-specific processes, potentially useful as targets for antiviral interventions, as well as new insights into fundamentals of eukayrotic translation. This project focuses on the CMV gpUL4 protein, synthesis of which is regulated by a short upstream open reading frame (uORF2) in the gpUL4 mRNA. Mutant viruses will be used to evaluate the effects of uORF2 alterations on regulation of gpUL4 expression and on viral replication. In conjunction with investigations of the consequences of ectopic gpUL4, these studies will illuminate the significance of gpUL4 translational regulation in the viral life cycle. A second series of experiments will elucidate the detailed molecular mechanism by which uORF2 regulates gene expression. Genetic studies using S. cerevisaie, complemented by molecular biological and biochemical assays in mammalian cells and cell extracts will delineate the precise step during translation termination that is controlled by uORF2 and will identify trans-acting factors that participate in this extraordinary regulatory mechanism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026672-13
Application #
6373141
Study Section
Virology Study Section (VR)
Program Officer
Beisel, Christopher E
Project Start
1988-08-01
Project End
2003-03-31
Budget Start
2001-07-01
Budget End
2003-03-31
Support Year
13
Fiscal Year
2001
Total Cost
$346,626
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Bayer, Avraham; Brennan, Greg; Geballe, Adam P (2018) Adaptation by copy number variation in monopartite viruses. Curr Opin Virol 33:7-12
Hickson, Sarah E; Margineantu, Daciana; Hockenbery, David M et al. (2018) Inhibition of vaccinia virus replication by nitazoxanide. Virology 518:398-405
Child, Stephanie J; Hickson, Sarah E; Bayer, Avraham et al. (2018) Antagonism of the Protein Kinase R Pathway in Human Cells by Rhesus Cytomegalovirus. J Virol 92:
Daugherty, Matthew D; Schaller, Aaron M; Geballe, Adam P et al. (2016) Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. Elife 5:
Mouna, Lina; Hernandez, Eva; Bonte, Dorine et al. (2016) Analysis of the role of autophagy inhibition by two complementary human cytomegalovirus BECN1/Beclin 1-binding proteins. Autophagy 12:327-42
Carpentier, Kathryn S; Esparo, Nicolle M; Child, Stephanie J et al. (2016) A Single Amino Acid Dictates Protein Kinase R Susceptibility to Unrelated Viral Antagonists. PLoS Pathog 12:e1005966
Gray, Elizabeth E; Winship, Damion; Snyder, Jessica M et al. (2016) The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA. Immunity 45:255-66
Braggin, Jacquelyn E; Child, Stephanie J; Geballe, Adam P (2016) Essential role of protein kinase R antagonism by TRS1 in human cytomegalovirus replication. Virology 489:75-85
Carpentier, Kathryn S; Geballe, Adam P (2016) An Evolutionary View of the Arms Race between Protein Kinase R and Large DNA Viruses. J Virol 90:3280-3
Brennan, Greg; Kitzman, Jacob O; Shendure, Jay et al. (2015) Experimental Evolution Identifies Vaccinia Virus Mutations in A24R and A35R That Antagonize the Protein Kinase R Pathway and Accompany Collapse of an Extragenic Gene Amplification. J Virol 89:9986-97

Showing the most recent 10 out of 28 publications